Shengya Fu Linjuan Li Xiaofen Li Qiang Wu Xiaohui Wang Yan Huang Haoyue Hu Dan Cao
10.3389/fphar.2022.888106
Front Pharmacol
2022 Aug 10;13:888106.
apatinib biomarker hyper-vascular metastatic gastric cancer second-line treatment
CC BY
https://pubmed.ncbi.nlm.nih.gov/36034835/
Case Reports
PMC9400896
36034835
Case report: Long-term partial response of apatinib plus paclitaxel as second-line therapy in a patient with metastatic gastric cancer
2022